PLTP Deficiency-mediated Atherosclerosis Regression Could Be Related to Sphinogosine-1-phosphate Reduction

Overview

Journal Atherosclerosis

Publisher Elsevier

Specialty Cardiology & Vascular Diseases

Date 2022 Aug 8

PMID 35940962

Authors

Jiao Zheng

Ke Zhang

Zhiqiang Li

Tilla S Worgall

Xian-Cheng Jiang

Affiliations

Soon will be listed here.

Citing Articles

Sphingosine 1-phosphate receptor 1signaling in macrophages reduces atherosclerosis in LDL receptor-deficient mice.

Poti F, Scalera E, Feuerborn R, Fischer J, Arndt L, Varga G JCI Insight. 2024; 9(24).

PMID: 39531328 PMC: 11665566. DOI: 10.1172/jci.insight.158127.

References

Bosteen M, Svarrer E, Stattau Bisgaard L, Martinussen T, Madsen M, Nielsen L . Effects of apolipoprotein M in uremic atherosclerosis. Atherosclerosis. 2017; 265:93-101. DOI: 10.1016/j.atherosclerosis.2017.08.005. View

Zhang K, Zheng J, Chen Y, Dong J, Li Z, Chiang Y . Inducible phospholipid transfer protein deficiency ameliorates atherosclerosis. Atherosclerosis. 2021; 324:9-17. PMC: 8096707. DOI: 10.1016/j.atherosclerosis.2021.03.011. View

Poti F, Gualtieri F, Sacchi S, Weissen-Plenz G, Varga G, Brodde M . KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice. Arterioscler Thromb Vasc Biol. 2013; 33(7):1505-12. DOI: 10.1161/ATVBAHA.113.301347. View

Kawahara A, Nishi T, Hisano Y, Fukui H, Yamaguchi A, Mochizuki N . The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors. Science. 2008; 323(5913):524-7. DOI: 10.1126/science.1167449. View

Yu Y, Guo S, Feng Y, Feng L, Cui Y, Song G . Phospholipid transfer protein deficiency decreases the content of S1P in HDL via the loss of its transfer capability. Lipids. 2013; 49(2):183-90. DOI: 10.1007/s11745-013-3850-y. View

Keul P, Lucke S, von Wnuck Lipinski K, Bode C, Graler M, Heusch G . Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis. Circ Res. 2010; 108(3):314-23. DOI: 10.1161/CIRCRESAHA.110.235028. View

Shelly L, Royer L, Sand T, Jensen H, Luo Y . Phospholipid transfer protein deficiency ameliorates diet-induced hypercholesterolemia and inflammation in mice. J Lipid Res. 2008; 49(4):773-81. DOI: 10.1194/jlr.M700336-JLR200. View

Obinata H, Kuo A, Wada Y, Swendeman S, Liu C, Blaho V . Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice. J Lipid Res. 2019; 60(11):1912-1921. PMC: 6824498. DOI: 10.1194/jlr.RA119000277. View

Shatrov V, Lehmann V, Chouaib S . Sphingosine-1-phosphate mobilizes intracellular calcium and activates transcription factor NF-kappa B in U937 cells. Biochem Biophys Res Commun. 1997; 234(1):121-4. DOI: 10.1006/bbrc.1997.6598. View

10.

Deckert V, Kretz B, Habbout A, Raghay K, Labbe J, Abello N . Development of abdominal aortic aneurysm is decreased in mice with plasma phospholipid transfer protein deficiency. Am J Pathol. 2013; 183(3):975-86. DOI: 10.1016/j.ajpath.2013.05.018. View

11.

Schlitt A, Liu J, Yan D, Mondragon-Escorpizo M, Norin A, Jiang X . Anti-inflammatory effects of phospholipid transfer protein (PLTP) deficiency in mice. Biochim Biophys Acta. 2005; 1733(2-3):187-91. DOI: 10.1016/j.bbalip.2004.12.011. View

12.

Liao C, Song M, Gao Y, Mauer A, Revzin A, Malhi H . Hepatocyte-Derived Lipotoxic Extracellular Vesicle Sphingosine 1-Phosphate Induces Macrophage Chemotaxis. Front Immunol. 2019; 9:2980. PMC: 6305739. DOI: 10.3389/fimmu.2018.02980. View

13.

Fisher E . Regression of Atherosclerosis: The Journey From the Liver to the Plaque and Back. Arterioscler Thromb Vasc Biol. 2015; 36(2):226-35. PMC: 4732981. DOI: 10.1161/ATVBAHA.115.301926. View

14.

Weigert A, Olesch C, Brune B . Sphingosine-1-Phosphate and Macrophage Biology-How the Sphinx Tames the Big Eater. Front Immunol. 2019; 10:1706. PMC: 6658986. DOI: 10.3389/fimmu.2019.01706. View

15.

Christoffersen C, Obinata H, Kumaraswamy S, Galvani S, Ahnstrom J, Sevvana M . Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc Natl Acad Sci U S A. 2011; 108(23):9613-8. PMC: 3111292. DOI: 10.1073/pnas.1103187108. View

16.

Obinata H, Hla T . Sphingosine 1-phosphate and inflammation. Int Immunol. 2019; 31(9):617-625. PMC: 6939830. DOI: 10.1093/intimm/dxz037. View

17.

Kuwano T, Bi X, Cipollari E, Yasuda T, Lagor W, Szapary H . Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport. J Lipid Res. 2017; 58(4):731-741. PMC: 5392748. DOI: 10.1194/jlr.M074625. View

18.

Skoura A, Michaud J, Im D, Thangada S, Xiong Y, Smith J . Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis. Arterioscler Thromb Vasc Biol. 2010; 31(1):81-5. PMC: 3013369. DOI: 10.1161/ATVBAHA.110.213496. View

19.

Murata N, Sato K, Kon J, Tomura H, Yanagita M, Kuwabara A . Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem J. 2000; 352 Pt 3:809-15. PMC: 1221521. View

20.

Ishimaru N, Yamada A, Nitta T, Arakaki R, Lipp M, Takahama Y . CCR7 with S1P1 signaling through AP-1 for migration of Foxp3+ regulatory T-cells controls autoimmune exocrinopathy. Am J Pathol. 2011; 180(1):199-208. DOI: 10.1016/j.ajpath.2011.09.027. View